homefeedbacksupportlog on 5-Jul-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


John N. Weinstein
Genomics & Bioinformatics Group, LMP, National Cancer Institute, Bethesda, United States of America

Faculty Member: PHARMACOLOGY & DRUG DISCOVERY > Cancer therapeutics [ since 4 May 2006 ]
[ Evaluations ]
to email [Help]
Evaluations

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1{alpha}.
Koh MY, Spivak-Kroizman T, …, Kirkpatrick DL, Powis G
Mol Cancer Ther 2008 Jan 7(1):90-100 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | John N. Weinstein
Evaluated 28 Jan 2008

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.
Lamb J, Crawford ED, …, Lander ES, Golub TR
Science 2006 Sep 29 313(5795):1929-35 [abstract on PubMed] [related articles] [FREE full text]
Selected by | John N. Weinstein
Evaluated 23 Oct 2006

^Top  Back to Faculty Members



© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info